RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer.

Liuying ZhuYuanhe WangYang ZhouQian Dong Yun-Peng Liu Jingdong Zhang

Published in: BioMed research international (2020)

There was a high overall consistency in KRAS mutational assessment between plasma, stool, and tissue samples. In stage IV patients, the consistency of KRAS gene detection between tissue and stools or plasma was higher.

Keyphrases

end stage renal disease
wild type
newly diagnosed
ejection fraction
chronic kidney disease
loop mediated isothermal amplification
peritoneal dialysis
real time pcr
copy number
patient reported outcomes
transcription factor